BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:53 PM
Jun 07, 2010
 |  BC Extra  |  Clinical News

NewLink presents HyperAcute Pancreas data

NewLink Genetics Corp. (Ames, Iowa) presented data from the open-label Phase II trial of HyperAcute Pancreas plus Gemzar gemcitabine and 5-fluorouracil (5-FU) to treat pancreatic cancer....

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >